Since we're off the DigiBoard, I don't recognize all the user names. However, anyone old or new to Generex should follow tc's advice. A long term plan has been disclosed by the company. Of course, we know that execution and funding have always been the issues. With one eye raised, I do believe things are different this time. No one should go all in, but I think it's wise to pick up shares on the dips. There are only 1,065,519 shares. The more those shares are in the hands of people with a long term view, the tighter the float will become. The tighter the float, the higher the price.
No pumping here. There is no reason to invest needed money in a spec like GNBT. However, as a spec, there is a lot to offer. (Where have I heard that before?) OTOH, no one can deny that 1:20 dividend (not stock split) is intriguing. Even a 50 share purchase will leave you with 1050 shares on 12/3. I would expect more PR's leading up to the 12/3 date. We've already had more PR's in two months than we've had in two years. At least that my sense of things. I haven't actually gone back to check the PR's.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links